18 May 2013
Keywords: celltech, shares, plunge, pfizer, delay, decision, uk
Article | 17 November 2003
The UK's largest biotechnology firm, Celltech, says that US drug majorPfizer, the development partner on its leading product candidate, has
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 November 2003
17 May 2013
© 2013 thepharmaletter.com